Cite
Naeshiro N, Aikata H, Hyogo H, et al. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2014;45(6):656-62doi: 10.1111/hepr.12400.
Naeshiro, N., Aikata, H., Hyogo, H., Kan, H., Fujino, H., Kobayashi, T., Fukuhara, T., Honda, Y., Nakahara, T., Ohno, A., Miyaki, D., Murakami, E., Kawaoka, T., Tsuge, M., Hiraga, N., Hiramatsu, A., Imamura, M., Kawakami, Y., Ochi, H., & Chayama, K. (2015). Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatology research : the official journal of the Japan Society of Hepatology, 45(6), 656-62. https://doi.org/10.1111/hepr.12400
Naeshiro, Noriaki, et al. "Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,6 (2015): 656-62. doi: https://doi.org/10.1111/hepr.12400
Naeshiro N, Aikata H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Nakahara T, Ohno A, Miyaki D, Murakami E, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. Hepatol Res. 2015 Jun;45(6):656-62. doi: 10.1111/hepr.12400. Epub 2014 Sep 02. PMID: 25088236.
Copy
Download .nbib